Effect of Follow-Up Endoscopy on the Outcomes of Patients with Inflammatory Bowel Disease

[1]  M. Neurath,et al.  Mucosal healing in inflammatory bowel diseases: a systematic review , 2012, Gut.

[2]  E. Kuipers,et al.  Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation , 2011, Inflammatory bowel diseases.

[3]  P. Rutgeerts,et al.  Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. , 2011, Gastroenterology.

[4]  M. Allez,et al.  Role of endoscopy in predicting the disease course in inflammatory bowel disease. , 2010, World journal of gastroenterology.

[5]  Eun Soo Kim,et al.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. , 2010, Gut and liver.

[6]  A. Kornbluth,et al.  Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee , 2010, The American Journal of Gastroenterology.

[7]  P. Rutgeerts,et al.  Mucosal healing and anti TNFs in IBD. , 2010, Current drug targets.

[8]  Laurent Beaugerie,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[9]  L. Peyrin-Biroulet,et al.  Clinical implications of mucosal healing for the management of IBD , 2010, Nature Reviews Gastroenterology &Hepatology.

[10]  P. Rutgeerts,et al.  Mucosal healing predicts long‐term outcome of maintenance therapy with infliximab in Crohn's disease , 2009, Inflammatory bowel diseases.

[11]  K. Thakkar,et al.  Repeat Endoscopy Affects Patient Management in Pediatric Inflammatory Bowel Disease , 2009, The American Journal of Gastroenterology.

[12]  F. Schmidt.  Meta-Analysis , 2008 .

[13]  J. Cheon,et al.  Recent advances of endoscopy in inflammatory bowel diseases. , 2007, Gut and liver.

[14]  M. Vatn,et al.  Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. , 2007, Gastroenterology.

[15]  P. Rutgeerts,et al.  Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? , 2007, Gut.

[16]  D. Faigel,et al.  ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. , 2006, Gastrointestinal endoscopy.

[17]  P. Rutgeerts,et al.  Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. , 2006, Gastrointestinal endoscopy.

[18]  T. Sørensen,et al.  Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies , 2005, The American Journal of Gastroenterology.

[19]  R. Farmer,et al.  Clinical patterns, natural history, and progression of ulcerative colitis , 1993, Digestive Diseases and Sciences.

[20]  R. Farrell,et al.  Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  P. Rutgeerts,et al.  Endoscopy in inflammatory bowel diseases , 2005 .

[22]  S. Travis,et al.  Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.

[23]  P. Rutgeerts,et al.  Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. , 2004, Gastroenterology.

[24]  A. Kornbluth,et al.  Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee , 2004, American Journal of Gastroenterology.

[25]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[26]  G. Pietrosi,et al.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis , 2001, American Journal of Gastroenterology.

[27]  Appropriate use of gastrointestinal endoscopy. , 2000, Gastrointestinal endoscopy.

[28]  G. D'Haens,et al.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.

[29]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.

[30]  V. Ponti,et al.  Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. , 1987, Gastroenterology.

[31]  H. Cooper,et al.  Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. , 1977, Gastroenterology.